"We should work toward improving care for our patients with right-sized antibiotic courses."
Resources & Literature
Recent Literature
Arias-Fernandez L, Montero JSR, Gil-Prieto R et al. Burden of pneumonia in patients with viral and bacterial coinfection in Spain during six consecutive influenza seasons, from 2009-10 to 2014-15. Vaccine 2021 (published online Jul 23)
Baker DL, Giuliano KK. Prevention practices for nonventilator hospital-acquired pneumonia: a survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN). Infect Control Hosp Epidemiol 2021 (published online Oct 4)
Carey E, Chen HYP, Baker D, et al. The association between non-ventilator associated hospital acquired pneumonia and patient outcomes among U.S. veterans. Am J Infect Control 2022 (published online Feb 26)
Chhatwal J, Sapru A, Sundaram B, et al. A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in India. Vaccine 2021 (published online Aug 6)
Chowers M, Gerassy-Vainberg S, Cohen-Poradosu R, et al. The effect of macrolides on mortality in bacteremic pneumococcal pneumonia: a retrospective, nationwide cohort study, Israel, 2009-2017. Clin Infect Dis 2022 (published online Apr 20)
Dananche C, Paranhos-Baccala G, Messaoudi M, et al. Nasopharyngeal viral and bacterial co-detection among children from low- and middle-income countries with and without pneumonia. Am J Trop Med Hyg 2022 (published online Feb 7)
Dinh A, Duran C, Ropers J, et al. Factors associated with treatment failure in moderately severe community-acquired pneumona. JAMA Netw Open 2021 Oct 15;4(10):e2129566
Falsey AR, Walsh EE, House S, et al. Risk factors and medical resource utilization of respiratory syncytial virus, human metapneumovirus and influenza related hospitalizations in adults –a global study during the 2017-2019 epidemic seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study). Open Forum Infect Dis 2021 (published online Oct 5)
Goncalves-Pereira JC, Marino F, Mergulhao P, et al. Hospital-acquired pneumonia is more frequent and lethal in stroke patients: a nationwide 4-year study. Infect Control Hosp Epidemiol 2021 (published online Sep 29)
Harris JG, Harris LA, Olarte L, et al. Improving pneumococcal vaccination rates in high-risk children in specialty clinics. Pediatrcs 2022 (published online Mar 2)
Hsiao A, Hansen J, Timbol J, et al. Incidence and estimated vaccine effectiveness against hospitalizations for all-cause pneumonia among older US adults who were vaccinated and not vaccinated with 13-valent pneumococcal conjugate vaccine. JAMA Netw Open 2022 Mar 18;5(3):e221111
Ignatova GL, Avdeev SN, and Antonov VN. Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study. Sci Rep 2021 Aug 5;11(15948)
Jiang M, Wang X, Zhu L, et al. Clinical characteristics, antimicrobial resistance, and risk factors for mortality in paediatric invasive pneumococcal disease in Beijing, 2012–2017. BMC Infect Dis 2022 (published online Apr 5)
Kabir A, Newall AT, Randall D, et al. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in medically at-risk children in Australia: a record linkage study. J Pediatric Infect Dis Soc 2022 (published online May 30)
Kim SK, Park I, Hong SJ, et al. Association between pneumonia and chronic otitis media: a nested case-control study using a national health screening cohort. Int J Infect Dis 2022 (published online Feb 19)
Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2022 (published online May 20)
Kobayashi M, Abdul-Karim A, Milucky JL, et al. Estimating the economic burden of pneumococcal meningitis and pneumonia in northern Ghana in the African meningitis belt post-PCV13 introduction. Vaccine 2021 (published online Jul 1)
Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep 2022 Jan 28;71(4):109–17
Mackenzie GA, Hill PC, Jeffries DH, et al, for the Gambia Pneumococcal Surveillance Group. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. Lancet Infect Dis 2021 (published online July 16)
Mahmoodpoor A, Shadvar K, Sanaie S, et al. Effect of vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study. BMC Infect Dis 2021 Jun 29;21:616
Malezieux-Picard A, Nasce A, Azurmendi L, et al. Kinetics of inflammatory biomarkers to predict one-year mortality in elderly patients hospitalized for pneumonia: a multivariable analysis. Int J Infect Dis 2022 (published online May 8)
Morga A, Kimura T, Feng Q, et al. Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine 2022 (published online Mar 12)
